➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
AstraZeneca
Express Scripts
Baxter
Boehringer Ingelheim

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Luliconazole - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for luliconazole and what is the scope of patent protection?

Luliconazole is the generic ingredient in one branded drug marketed by Medicis and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Luliconazole has sixty-four patent family members in twenty-five countries.

There are six drug master file entries for luliconazole. One supplier is listed for this compound.

Summary for luliconazole
Drug Prices for luliconazole

See drug prices for luliconazole

Recent Clinical Trials for luliconazole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Valeant PharmaceuticalsPhase 4
Valeant Pharmaceuticals International, Inc.Phase 4
Bausch & Lomb IncorporatedPhase 4

See all luliconazole clinical trials

Pharmacology for luliconazole

US Patents and Regulatory Information for luliconazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes   Start Trial   Start Trial   Start Trial
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
McKesson
Baxter
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.